Strides Pharma Half Yearly Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Sep-2022	Mar-2022	Sep-2021	Mar-2021	Sep-2020
Gross Sales	1837.17	1660.41	1409.84	1740.52	1575.36
Excise Duty	--	--	--	--	--
Net Sales	1837.17	1660.41	1409.84	1740.52	1575.36
Other Operating Income	--	--	--	--	--
Other Income	70.10	96.25	35.74	10.72	98
Total Income	1907.27	1756.66	1445.58	1751.24	1673.35
Total Expenditure	1845.89	1777.01	1667.99	1469.42	1309.44
PBIDT	61.38	(20.35)	(222.40)	281.82	363.91
Interest	122.18	91.74	85.01	76.29	73.78
PBDT	(60.81)	(112.09)	(307.41)	205.53	290.14
Depreciation	122.10	121.57	111.44	104.37	101.92
Minority Interest Before NP	--	--	--	--	--
Tax	(13.96)	(156.39)	5.95	6.97	14.48
Deferred Tax	(52.52)	20.43	(48.25)	15.30	(5.10)
Reported Profit After Tax	(116.43)	(97.70)	(376.55)	78.90	178.83
Minority Interest After NP	(3.36)	(5.25)	(8.79)	(5.03)	(5.68)
Net Profit after Minority Interest	(113.07)	(92.45)	(367.76)	83.93	184.51
Extra-ordinary Items	(32.68)	(92.38)	(149.30)	(14.70)	53.20
Adjusted Profit After Extra-ordinary item	(80.39)	(0.07)	(218.46)	98.63	131.31
EPS (Unit Curr.)	(12.58)	--	(40.99)	9.36	20.60
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	90.29	89.79	89.78	89.66	89.63
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	3.34	(1.23)	(15.78)	16.19	23.10
PBDTM(%)	--	--	--	--	--
PATM(%)	(6.34)	(5.88)	(26.71)	4.53	11.35